Nuprobe global adopts bionano's saphyr® system to develop products in reproductive health and oncology applications

San diego and shanghai, china, sept. 07, 2021 (globe newswire) -- bionano genomics, inc. (nasdaq: bngo) announced today that nuprobe global, a global molecular diagnostics company based in shanghai, china and houston, texas, has adopted bionano's saphyr system for optical genome mapping (ogm) to integrate their quantitative amplicon sequencing (qaseq) and blocker displacement amplification (bda) technologies for research and product development in the fields of reproductive health and oncology liquid biopsies.
BNGO Ratings Summary
BNGO Quant Ranking